Researcher @broadinstitute. Medical student @KU_Leuven. Cardiovascular sciences, pregnancy complications, aging-related disease mechanisms, and multi-omics.
België
Joined August 2017
- Tweets1K
- Following689
- Followers721
- Likes2.7K
Pinned Tweet
What does the circulating proteome teach us about common heart diseases?
Thrilled to share our analysis identifying new biomarkers, drug targets, and prediction models for these conditions.
Co-led by @APournamdari, with @mchonig and @pnatarajanmd nature.com/articles/s44161-0… (1/x)
Art Schuermans retweeted
🎉 Our new study in @ScienceTM is featured by @MGBResearchNews and @harvardmed! Leveraging both machine-learning imaging and genomics, we uncovered an underappreciated link between spleen and coronary artery disease🫀- pointing to new potential mechanisms and targets. w/ @pnatarajanmd M. Kamineni @VineetRaghu2 @_ahmedmalaa @buutrg @artschuermans @lucidtronix @reeder_ml @patrick_ellinor @MahnazMaddah
hms.harvard.edu/news/researc…
Art Schuermans retweeted
Our study led by M. Kamineni & with @ZhiYu_ACGT uses imaging and genomics to prioritize a role for the spleen in coronary artery disease science.org/doi/10.1126/scit… @ScienceTM
Art Schuermans retweeted
Excited to share our work on clonal hematopoiesis and cardiovascular-kidney-metabolic syndrome published in @ESC_Journals simultaneous with #ESC2026!
Special thanks to my amazing mentor @mchonig and the entire team!
academic.oup.com/eurheartj/a… (1/x)
Art Schuermans retweeted
This is simply outstanding! What wonderful mentors @mchonig @pnatarajanmd 👏🏽👏🏽👏🏽 to let a medical student present and she was outstanding!
Art Schuermans retweeted
The new @TheLancet Series on CVD in🤰 launched at #ESC2026!
Across 3 papers, the Series spans CVD in🤰→CV health across the life course
In paper #3, we focus on what comes next: how APOs signal future CVD risk, and an opportunity for earlier prevention. lnkd.in/g4Vu2jYF
Art Schuermans retweeted
Excited to share our new manuscript out in @JACCJournals! jacc.org/doi/10.1016/j.jacc.… We present a clinical polygenic risk report for 8 cardiovascular conditions, now available as an orderable test 🧬❤️ 🧵⬇️ 1/9
Art Schuermans retweeted
Out in @JAMACardio! Does clonal hematopoiesis (CHIP) raise the risk of inflammatory heart disease in US patients? Last year, @artschuermans & @mchonig elegantly showed this in the UK Biobank. We wanted to know if it replicates.
jamanetwork.com/journals/jam… (1/4)
Art Schuermans retweeted
Grateful to share that I’ve been promoted to Professor of Medicine @harvardmed @Harvard.
I am deeply thankful for my family, mentors, collaborators, and trainees who have carried me here.
Art Schuermans retweeted
Excited to share our preprint led by @AeronSmallMD M. Yu @btakiy A. Georges & with @n_bouatianaji describing the genetic architecture of mitral valve prolapse across 2.2M individuals, integrating mitral valve apparatus & extra-valvular multi-omics - New therapeutic hypotheses nominated in MVP, myocardial fibrosis, & subclinical arrhythmia traits medrxiv.org/content/10.64898… @medrxivpreprint
Art Schuermans retweeted
Thanks to Panagiotis Zangas for leading this and to @artschuermans for his insights.
🔗link to the paper: sciencedirect.com/science/ar…
Art Schuermans retweeted
Last year, we developed a genetic proxy of IL-6 signaling inhibition that we showed to predict reductions in atherosclerotic cardiovascular disease risk.
Now, we also show reductions in risk of heart failure (both with preserved and reduced ejection fraction).
Art Schuermans retweeted
New online! Reframing atherothrombosis through the inflammation hypothesis dlvr.it/TRwLyK
Art Schuermans retweeted
Pleased to share our new @Circ_Gen article:
Dr. Peter Libby and I present the spectrum of patients referred to cardiology for clonal hematopoiesis, define context- and biology-based categories, and outline a structured approach to CV evaluation and management
Link below
Happy to share this "journal club" on one of the first studies linking inflammation to atherosclerotic disease.
I discuss Ridker et al.'s 1997 analysis on CRP and ischemic events: doi.org/10.1056/nejm19970403…
Read it below - published today at @NatRevCardiol: doi.org/10.1038/s41569-026-0…
Art Schuermans retweeted
Lp(a)-related VTE risk is not uniform & appears hormone-dependent: signal in premenopausal👩🦰and postmenopausal👩🦰on MHT, but not in👨🦰. Sim pub with #ACC.26 @ehj_ed. Congrats @daniel_ezt and 🙏 to co-authors & my co-senior author, mentor & friend @mchonig
academic.oup.com/eurheartj/a…
Art Schuermans retweeted
Huge congrats to @NiekMohamma @radboudumc for receiving this year's @JACCJournals JACC Parmley Prize for his work on colchicine and clonal hematopoiesis #CHIP 🩸🧬 in LoDoCo2 ❤️🔥(jacc.org/doi/10.1016/j.jacc.…)
and to all of the honorees at ACC26 (acc.org/About-ACC/Press-Rele…)
Art Schuermans retweeted
Great editorial from @PamTaubMD @hsbhatia here: academic.oup.com/eurheartj/a…
🙏 to co-senior @mapabonp + co-authors including @NiekMohamma @artschuermans @DrM_ODonoghue @bbikdeli @ZhiYu_ACGT @pnatarajanmd @AniruddhPatelMD + others @MGHHeartHealth
Art Schuermans retweeted
Now in @ehj_ed #EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt
Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, + postmenopausal 👭 using hormone therapy)
Paper here: academic.oup.com/eurheartj/a…
Art Schuermans retweeted
Our manuscript led by @NakaoTetsushi @skoyamamd - a comprehensive characterization of leukocyte telomere length (LTL), a hallmark of biological aging across the US nature.com/articles/s41588-0… @NatureGenet
Quick summary of lessons learned:
